Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions
- 24 December 2014
- journal article
- review article
- Published by Wiley in Risk Analysis
- Vol. 36 (7), 1297-1314
- https://doi.org/10.1111/risa.12331
Abstract
Economic analyses for vaccine-preventable diseases provide important insights about the value of prevention. We reviewed the literature to identify all of the peer-reviewed, published economic analyses of interventions related to measles and rubella immunization options to assess the different types of analyses performed and characterize key insights. We searched PubMed, the Science Citation Index, and references from relevant articles for studies in English and found 67 analyses that reported primary data and quantitative estimates of benefit-cost or cost-effectiveness analyses for measles and/or rubella immunization interventions. We removed studies that we characterized as cost-minimization analyses from this sample because they generally provide insights that focused on more optimal strategies to achieve the same health outcome. The 67 analyses we included demonstrate the large economic benefits associated with preventing measles and rubella infections using vaccines and the benefit of combining measles and rubella antigens into a formulation that saves the costs associated with injecting the vaccines separately. Despite the importance of population immunity and dynamic viral transmission, most of the analyses used static models to estimate cases prevented and characterize benefits, although the use of dynamic models continues to increase. Many of the analyses focused on characterizing the most significant adverse outcomes (e.g., mortality for measles, congenital rubella syndrome for rubella) and/or only direct costs, and the most complete analyses present data from high-income countries.Keywords
Funding Information
- Centers for Disease Control and Prevention (U66IP000519)
This publication has 109 references indexed in Scilit:
- Health economics of rubella: a systematic review to assess the value of rubella vaccinationBMC Public Health, 2013
- A locally initiated and executed measles outbreak response immunization campaign in the nylon health district, Douala Cameroon 2011BMC Research Notes, 2013
- The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective studyBMC Health Services Research, 2011
- Synthesizing epidemiological and economic optima for control of immunizing infectionsProceedings of the National Academy of Sciences of the United States of America, 2011
- The Cost-Effectiveness of Supplementary Immunization Activities for Measles: A Stochastic Model for UgandaThe Journal of Infectious Diseases, 2011
- Replacing the measles ten-dose vaccine presentation with the single-dose presentation in ThailandVaccine, 2011
- Health Care-Associated Measles Outbreak in the United States After an Importation: Challenges and Economic ImpactThe Journal of Infectious Diseases, 2011
- Single versus multi-dose vaccine vials: An economic computational modelVaccine, 2010
- Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003BMC Public Health, 2007
- Pharmacoeconomics of ImmunisationPharmacoEconomics, 1993